152 related articles for article (PubMed ID: 19491721)
21. Retinopathy of Great Pyrenees dogs: fluorescein angiography, light microscopy and transmitting and scanning electron microscopy.
Grahn BH; Cullen CL
Vet Ophthalmol; 2001 Sep; 4(3):191-9. PubMed ID: 11722783
[TBL] [Abstract][Full Text] [Related]
22. Identifying central serous chorioretinopathy biomarkers in coexisting diabetic retinopathy: a multimodal imaging study.
Dhurandhar DS; Singh SR; Sahoo NK; Goud A; Lupidi M; Chhablani J
Br J Ophthalmol; 2020 Jul; 104(7):904-909. PubMed ID: 31563867
[TBL] [Abstract][Full Text] [Related]
23. The association between visual function and retinal structure in chronic central serous chorioretinopathy.
Sugiura A; Fujino R; Takemiya N; Shimizu K; Matsuura M; Murata H; Inoue T; Obata R; Asaoka R
Sci Rep; 2017 Nov; 7(1):16288. PubMed ID: 29176603
[TBL] [Abstract][Full Text] [Related]
24. Retinal flavoprotein fluorescence correlates with mitochondrial stress, apoptosis, and chemokine expression.
Field MG; Yang D; Bian ZM; Petty HR; Elner VM
Exp Eye Res; 2011 Oct; 93(4):548-55. PubMed ID: 21767533
[TBL] [Abstract][Full Text] [Related]
25. Pattern ERG in central serous retinopathy.
Goyal JL; Ghosh B; Sangit V; Kumar S; Jain P; Veerwal V; Arora R
Doc Ophthalmol; 2015 Apr; 130(2):141-7. PubMed ID: 25542207
[TBL] [Abstract][Full Text] [Related]
26. Eye for modeling visual distortion in central serous retinopathy.
Turuwhenua J
Optom Vis Sci; 2011 Nov; 88(11):1363-8. PubMed ID: 21892115
[TBL] [Abstract][Full Text] [Related]
27. Photopigments in central serous chorioretinopathy.
Ojima A; Iida T; Sekiryu T; Maruko I; Sugano Y
Am J Ophthalmol; 2011 Jun; 151(6):940-952.e1. PubMed ID: 21457927
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of central serous chorioretinopathy with optical coherence tomography.
Iida T; Hagimura N; Sato T; Kishi S
Am J Ophthalmol; 2000 Jan; 129(1):16-20. PubMed ID: 10653407
[TBL] [Abstract][Full Text] [Related]
29. Short-Term Retinal Sensitivity and Metamorphopsia Changes following Half-Fluence Photodynamic Therapy in Central Serous Chorioretinopathy.
Casalino G; Del Turco C; Corvi F; Rafaeli O; Bandello F; Querques G
Ophthalmic Res; 2016; 56(1):23-9. PubMed ID: 27003789
[TBL] [Abstract][Full Text] [Related]
30. Nondamaging photothermal therapy for the retina: initial clinical experience with chronic central serous retinopathy.
Lavinsky D; Palanker D
Retina; 2015 Feb; 35(2):213-22. PubMed ID: 25158944
[TBL] [Abstract][Full Text] [Related]
31. THE EFFECT OF PHOTOPIGMENT BLEACHING ON FUNDUS AUTOFLUORESCENCE IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY.
Choi KE; Yun C; Kim YH; Kim SW; Oh J; Huh K
Retina; 2017 Mar; 37(3):568-577. PubMed ID: 27429375
[TBL] [Abstract][Full Text] [Related]
32. Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results.
Fujita K; Yuzawa M; Mori R
Retina; 2011 Apr; 31(4):772-8. PubMed ID: 20890236
[TBL] [Abstract][Full Text] [Related]
33. Low luminance visual acuity in patients with central serous chorioretinopathy.
Fujita K; Shinoda K; Matsumoto CS; Imamura Y; Mizutani Y; Tanaka E; Mizota A; Oda K; Yuzawa M
Clin Exp Optom; 2013 Jan; 96(1):100-5. PubMed ID: 22963010
[TBL] [Abstract][Full Text] [Related]
34. Fundus autofluorescence in acute and chronic central serous chorioretinopathy.
Dinc UA; Tatlipinar S; Yenerel M; Görgün E; Ciftci F
Clin Exp Optom; 2011 Sep; 94(5):452-7. PubMed ID: 21480989
[TBL] [Abstract][Full Text] [Related]
35. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
[TBL] [Abstract][Full Text] [Related]
36. Bilateral central serous chorio-retinopathy in pregnancy presenting with severe visual loss.
Chakraborti C; Samanta SK; Faiduddin K; Choudhury KP; Kumar S; Mondal R
Nepal J Ophthalmol; 2014; 6(2):220-3. PubMed ID: 25680252
[TBL] [Abstract][Full Text] [Related]
37. OCTA characterisation of microvascular retinal alterations in patients with central serous chorioretinopathy.
Battista M; Borrelli E; Parravano M; Gelormini F; Tedeschi M; De Geronimo D; Sacconi R; Querques L; Bandello F; Querques G
Br J Ophthalmol; 2020 Oct; 104(10):1453-1457. PubMed ID: 31949095
[TBL] [Abstract][Full Text] [Related]
38. Central serous chorioretinopathy: risk factors for serous retinal detachment in fellow eyes.
Shinojima A; Mehanna C; Lavia CA; Gaudric A; Tadayoni R; Bousquet E
Br J Ophthalmol; 2020 Jun; 104(6):852-856. PubMed ID: 31473627
[TBL] [Abstract][Full Text] [Related]
39. Retinal vessels functionality in eyes with central serous chorioretinopathy.
Tomasso L; Benatti L; Rabiolo A; Carnevali A; Zucchiatti I; Querques L; Bandello F; Querques G
Br J Ophthalmol; 2018 Feb; 102(2):210-214. PubMed ID: 28600300
[TBL] [Abstract][Full Text] [Related]
40. [Minute granular lesions of the retinal pigment epithelium related to choroidal hyperpermeability in patients with central serous chorioretinopathy].
Takeda M; Sato Y
Nippon Ganka Gakkai Zasshi; 2013 Jan; 117(1):44-9. PubMed ID: 23424975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
